(Q50962746)

English

The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population.

scientific article published in July 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population. (English)

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

Anna Maria Fulghesu

4

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

Alessio Farcomeni

7

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

16

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

author name string

A Capalbo

1

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

F Sagnella

2

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

R Apa

3

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

A Lanzone

5

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

A Morciano

6

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

M F Gangale

8

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

F Moro

9

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

D Martinez

10

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

A Ciardulli

11

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

C Palla

12

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

M L Uras

13

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

F Spettu

14

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

A Cappai

15

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

G Neri

17

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

F D Tiziano

18

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

publication date

1 July 2012

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

Clinical Endocrinology

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

77

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

1

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

113-119

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

A twin study of polycystic ovary syndrome and lipids.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Heritability and the risk of developing androgen excess

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Metabolic phenotype in the brothers of women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Candidate genes in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Polycystic ovarian disease: heritability and heterogeneity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Structure of the human luteinizing hormone-choriogonadotropin receptor gene: unusual promoter and 5' non-coding regions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

LH receptor gene mutations and polymorphisms: an overview

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Transgenic and knockout mouse models for the study of luteinizing hormone and luteinizing hormone receptor function.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Activation of the luteinizing hormone receptor in the extracellular domain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Mutations in human gonadotropin and gonadotropin-receptor genes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Male LH-independent sexual precocity in a 3.5-year-old boy caused by a somatic activating mutation of the LH receptor in a Leydig cell tumor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Leydig cell hypoplasia: absent luteinizing hormone receptor cell surface expression caused by a novel homozygous mutation in the extracellular domain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Gonadotropin-Independent Familial Sexual Precocity with Premature Leydig and Germinal Cell Maturation (Familial Testotoxicosis): Effects of a Potent Luteinizing Hormone-Releasing Factor Agonist and Medroxyprogesterone Acetate Therapy in Four Cases*

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

A common polymorphism renders the luteinizing hormone receptor protein more active by improving signal peptide function and predicts adverse outcome in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Genetics of population isolates.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2012.04372.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2012.04372.X

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22356187

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50962746&oldid=1588421744"